HiberCell
ID: 5874687HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
2
Funding Rounds
$128.2m
Money raised
Recent Funding Rounds
Overview
HiberCell is a New York-based biotechnology company developing therapeutics to prevent relapse and metastasis.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ar* No****** M.*** Ph*** |
|
- | - |
| Al** Ri**** Ph*** |
|
- | - |
| Ju*** Ag************ Ph*** |
|
- | - |
Funding series
Funding Series Analysis
The company HiberCell has raised a total of $67.4m in funding over 2 rounds.
Key Insights:
- HiberCell Series B round, May 2021: $67.4m
- HiberCell funding round, February 2019: $60.75m
Industries
HiberCell is active in the following industries: